Ampere Generator
Irvine Biomedical,Inc.(Ibi) · Decision date Aug 7, 2026
What did the FDA approve?
FDA records P040042/S059 as a supplement to PMA P040042, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Aug 7, 2026.
FDA approval order statement
approval for firmware changes to the TactiSys Quartz Equipment v1.8.0 and Ampere Generator v1.2.0 to maintain compatibility with the TactiFlex Duo Ablation Catheter, Sensor Enabled
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 7, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P040042/S059
- Regulatory pathway
- PMA supplement
- Applicant
- Irvine Biomedical,Inc.(Ibi)
- Product code
- OAD
- Decision code
- APPR
- Decision date
- Aug 7, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter.
- Applicant
- Irvine Biomedical,Inc.(Ibi)
- Product code
- OAD
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P040042. Subsequent supplements may change the device or its indications.
FDA decision timeline
P040042 · Original PMA
THERAPY DUAL 8 CARDIAC ABLATION SYSTEM,THERAM 8MM THERMISTER ABLATION CATHETER SAFIRE TX ABLATION CATHETER
P040042/S058 · Related supplement
Safire TX Bi-directional and Therapy Dual-8
P040042/S059 received
Application receipt date recorded by FDA.
P040042/S059 · FDA decision
Real-Time Process
P040042/S060 · Related supplement
Therapy Dual-8 Ablation Catheter
Timeline entries are records held by MedtechLedger for P040042. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P040042
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Irvine Biomedical,Inc.(Ibi) | PMA approval | Nov 18, 2005 | FDA | |
Safire TX Bi-directional and Therapy Dual-8P040042/S058 | Irvine Biomedical,Inc.(Ibi) | PMA supplement | Jan 15, 2026 | FDA |
Therapy Dual-8 Ablation CatheterP040042/S060 | Irvine Biomedical,Inc.(Ibi) | PMA supplement | Sep 3, 2026 | FDA |
Explore the linked device profile
Other records with product code OAD
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biosense Webster, Inc. | PMA supplement | Sep 15, 2026 | FDA | |
THERMOCOOL SMARTTOUCH SF CatheterP030031/S142 | Biosense Webster, Inc. | PMA supplement | Sep 2, 2026 | FDA |
Ampere GeneratorP060019/S059 | Irvine Biomedical, Inc. | PMA supplement | Aug 7, 2026 | FDA |
Ampere GeneratorP110016/S095 | ABBOTT MEDICAL | PMA supplement | Aug 7, 2026 | FDA |
Dual Energy THERMOCOOL SMARTTOUCH SF SystemP030031/S141 | Biosense Webster, Inc. | PMA supplement | Jul 1, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Irvine Biomedical,Inc.(Ibi)
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 2375 Morse Ave., Irvine, CA, 92614
Sources and methodology
- Original FDA record: P040042/S059
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



